bucladesine and Animal Mammary Carcinoma
bucladesine has been researched along with Animal Mammary Carcinoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Angelberger, P; Dudczak, R; Gludovacz, D; Koller, E; Li, SR; Patri, P; Valent, P; Virgolini, I; Yang, Q | 1 |
Other Studies
1 other study(ies) available for bucladesine and Animal Mammary Carcinoma
Article | Year |
---|---|
Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells.
Topics: Bucladesine; Carcinoma, Squamous Cell; Cyclic AMP; Indium Radioisotopes; Kinetics; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Mammary Neoplasms, Animal; Receptors, Lipoprotein; Somatostatin; Temperature; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 2001 |